BridgeMD
New treatment option for Hidradenitis Suppurativa
Official title Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
ClinicalTrials.gov ID: NCT06058520
What this study is testing
What is Fecal Microbiota - lyophilized?
Fecal Microbiota - lyophilized is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for hidradenitis suppurativa.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- HS is relatively common in the United States with a prevalence of 0.1-1.0%. 1 HS has a dramatic impact on quality of life, significantly more so than other chronic skin diseases, such as psoriasis or atopic dermatitis (AD).
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Able and willing to provide informed consent
- English speaking
- Age \>= 18years of age
- Diagnosis of hidradenitis suppurativa by a dermatologist
- Women who are not post-menopausal (at least 12 months of non-therapy induced amenorrhea) or surgically sterile (e.g. absence of ovaries and/or...
You likely can't join if
- Non-English speaking
- Refusal or inability to provide informed consent
- Planning on moving within 6 months from start of study
- Allergy to neomycin or vancomycin
- Anaphylactic food allergies
- Pregnancy, breastfeeding or planning pregnancy during study period (negative pregnancy test needed for persons of childbearing potential)
See the full eligibility criteria
- Able and willing to provide informed consent
- English speaking
- Age \>= 18years of age
- Diagnosis of hidradenitis suppurativa by a dermatologist
- Women who are not post-menopausal (at least 12 months of non-therapy induced amenorrhea) or surgically sterile (e.g. absence of ovaries and/or uterus) must remain abstinent or use a highly effective form of birth...
- Able to comply to study measures in the opinion of the investigator.
- Stable doses of all medications for 30 days prior to baseline
- Non-English speaking
- Refusal or inability to provide informed consent
- Planning on moving within 6 months from start of study
- Allergy to neomycin or vancomycin
- Anaphylactic food allergies
- Pregnancy, breastfeeding or planning pregnancy during study period (negative pregnancy test needed for persons of childbearing potential)
- Use of any topical or oral antibiotics within 30 days of randomization
- Use of any oral antibiotics within 90 days of randomization
- History of inflammatory bowel disease
- Extensive bowel resection (e.g., subtotal colectomy, substantial removal of small bowel)
- No major bowel surgery within 4 weeks prior to baseline or planned major surgery during the study period
- No active skin disease other than HS that could interfere with assessments
The study team makes the final eligibility decision.
Where it's taking place
- Minneapolis, Minnesota, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Minneapolis, Minnesota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.